Company Name

Industry

Location

Revenue

Employees

Macrocyclics

Biotechnology

United States, Texas

$5M to $10M

11-50

Volastra Therapeutics

Biotechnology

United States, New York

$5M to $10M

11-50

Gloucester Marine Genomics Institute

Biotechnology

United States, Massachusetts

$5M to $10M

11-50

Q32 Bio

Biotechnology

United States, Massachusetts

$5M to $10M

11-50

Aerami Therapeutics

Biotechnology

United States, North Carolina

$5M to $10M

11-50

Highline Sciences

Biotechnology

United States, California

$5M to $10M

11-50

IFM Therapeutics

Biotechnology

United States, Massachusetts

$5M to $10M

11-50

Studylog Systems

Biotechnology

United States, California

$5M to $10M

11-50

Abzyme Therapeutics

Biotechnology

United States, Pennsylvania

$5M to $10M

11-50

Vesigen Therapeutics

Biotechnology

United States, Massachusetts

$5M to $10M

11-50

Vanqua Bio

Biotechnology

United States, Illinois

$5M to $10M

11-50

Atarraya

Biotechnology

United States, Indiana

$5M to $10M

11-50

AlphaBio

Biotechnology

United States, Nevada

$5M to $10M

11-50

Glass Expansion

Biotechnology

United States, Massachusetts

$5M to $10M

11-50

Groff North America

Biotechnology

United States, Pennsylvania

$5M to $10M

11-50

Superbrewed Food

Biotechnology

United States, Delaware

$5M to $10M

11-50

Green Point Hemp

Biotechnology

United States, Florida

$5M to $10M

11-50

Lifecode

Biotechnology

United States, California

$5M to $10M

11-50

VitroLabs

Biotechnology

United States, California

$5M to $10M

11-50

Acumen Medical Communications

Biotechnology

United States, Massachusetts

$5M to $10M

11-50